DE1695017A1 - Verfahren zur Herstellung von neuen Derivaten des Sulfanilamids(II) - Google Patents

Verfahren zur Herstellung von neuen Derivaten des Sulfanilamids(II)

Info

Publication number
DE1695017A1
DE1695017A1 DE19671695017 DE1695017A DE1695017A1 DE 1695017 A1 DE1695017 A1 DE 1695017A1 DE 19671695017 DE19671695017 DE 19671695017 DE 1695017 A DE1695017 A DE 1695017A DE 1695017 A1 DE1695017 A1 DE 1695017A1
Authority
DE
Germany
Prior art keywords
cyclopropyl
group
general formula
compounds
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19671695017
Other languages
German (de)
English (en)
Inventor
Markus Dr Zimmermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JR Geigy AG filed Critical JR Geigy AG
Publication of DE1695017A1 publication Critical patent/DE1695017A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19671695017 1966-04-13 1967-04-12 Verfahren zur Herstellung von neuen Derivaten des Sulfanilamids(II) Pending DE1695017A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH535166A CH475995A (de) 1966-04-13 1966-04-13 Verfahren zur Herstellung von neuen Derivaten des Sulfanilamids

Publications (1)

Publication Number Publication Date
DE1695017A1 true DE1695017A1 (de) 1971-04-08

Family

ID=4292111

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19671695017 Pending DE1695017A1 (de) 1966-04-13 1967-04-12 Verfahren zur Herstellung von neuen Derivaten des Sulfanilamids(II)

Country Status (7)

Country Link
BE (1) BE696943A (cs)
CH (1) CH475995A (cs)
DE (1) DE1695017A1 (cs)
DK (1) DK113432B (cs)
ES (1) ES339209A1 (cs)
GB (1) GB1190982A (cs)
NL (1) NL6705168A (cs)

Also Published As

Publication number Publication date
ES339209A1 (es) 1968-05-16
BE696943A (cs) 1967-10-12
CH475995A (de) 1969-07-31
DK113432B (da) 1969-03-24
NL6705168A (cs) 1967-10-16
GB1190982A (en) 1970-05-06

Similar Documents

Publication Publication Date Title
DE2341925A1 (de) Neue pyrimidinderivate und verfahren zu ihrer herstellung
DD150609A5 (de) Verfahren zur herstellung von pyrimidin-verbindungen
EP0122580B1 (de) Pyrimidinderivate, deren Herstellung und pharmazeutische Präparate
DE2165962A1 (de) 4-Hydroxy-6-arylpyrimidine. Ausscheidung aus: 2149249
DE2849537A1 (de) Substituierte 5-(2-imidazolin-2-yl)- aminopyrimidine und verfahren zu deren herstellung
EP0000334B1 (de) 2,4--Diamino-5-benzylpyrimidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE1695017A1 (de) Verfahren zur Herstellung von neuen Derivaten des Sulfanilamids(II)
DE2209470A1 (de) Verfahren zur Herstellung von neuen Jodäthinylverbindungen
DE1695016A1 (de) Verfahren zur Herstellung von neuen Derivaten des Sulfanilamids(I)
DE3427823A1 (de) 5-subst.-(1,2,4) triazolo (1,5-c) pyrimidin-2-amine
DE2903850A1 (de) 2-amino-8-cyclopropyl-5-oxo-5,8- dihydro-pyrido eckige klammer auf 2,3-d eckige klammer zu -pyrimidin-6-carnonsaeuren, verfahren zu ihrer herstellung sowie ihrer verwendung als antibakterielle mittel
DE1545944A1 (de) Verfahren zur Herstellung von neuen Sulfonamiden der Pyrimidinreihe
DE451733C (de) Verfahren zur Darstellung von dicyklischen und polycyklischen Verbindungen, die hydrierte oder nichthydrierte Imidazol- oder Pyrimidinkerne enthalten
DE2715675C2 (cs)
DD201902A5 (de) Neues verfahren zur herstellung von imidazo/4,5-b/pyridinen und -pyrimidinen
DE1620700A1 (de) 2,4-Diamino-7-chlorpyrido[2,3-d]pyrimidine und Verfahren zu ihrer Herstellung
DE2937023A1 (de) Neue substituierte 5-(2-imidazolin-2-yl)-aminopyrimidine und verfahren zu deren herstellung
DE1695012C3 (de) N hoch 1 -(6-Cyclopropyl-4-pyrimidinyl)-sulfanilamide
DE818644C (de) Verfahren zur Herstellung von 3-Mercaptopyridin und dessen Salzen
DE1695012A1 (de) Verfahren zur Herstellung von neuen Derivaten des Sulfonamids
DE1814082C3 (de) Herstellung und ihre Weiterverarbeitung zu Pyrazolopyrimidinen
DE1670346C3 (de) Borhaltige heterocyclische Verbindungen und Verfahren zu deren Herstellung
DE1445531B2 (de) In 5-stellung substituierte 2-benzolsulfonamidopyrimidine und verfahren zu deren herstellung
AT251583B (de) Verfahren zur Herstellung neuer 6-(p-Aminobenzolsulfonamido)-pyrimidine
DD157192A1 (de) Verfahren zur synthese von 2-funktionalisierten 4-alkylthio-6-amino-pyrimidin-5-carbonitrilen